18th Annual NATA Symposium Scientific Programme

Scientific Programme

Thursday, April 20, 2017

MORNING

8:50-9:00 NATA Chair’s welcome address
Jean-François Hardy, Montreal, QC, Canada
 

Auditorium

PATIENT BLOOD MANAGEMENT IN MAJOR SURGERY
– STATE OF THE ART

Toby Richards, London, UK
Marco Pavesi, Milan, Italy


9:00-9:10 What is important and where should we go?
Marco Ranucci, Milan, Italy

9:10-9:20 PBM in paediatrics – is it feasible?
David Faraoni, Toronto, ON, Canada

9:20-9:30 Surgical techniques and topical haemostatic agents in PBM
Luca Weltert, Rome, Italy

9:30-9:40 PBM in Italy – national guidelines
Giancarlo Liumbruno, Rome, Italy

9:40-9:50 Bundles and implementation – how how how…
Kai Zacharowski, Frankfurt, Germany

9:50-10:00 Quality management in PBM – audits and benchmarking
Philippe Van der Linden, Brussels, Belgium

10:00-10:30 Discussion


10:30-11:00 Break


Auditorium

DIRECT ORAL ANTICOAGULANTS IN 2017
– STANDARDS AND NEW PARADIGMS

Charles-Marc Samama, Paris, France
Andrea De Gasperi, Milan, Italy


11:00-11:15 Perioperative management of DOACs in elective and emergency surgery: an update
Charles-Marc Samama, Paris, France

11:15-11:30 DOACs and loco-regional anaesthesia: when is it safe?
Juan V. Llau Pitarch, Valencia, Spain

11:30-11:45 Management of DOAC-associated bleeding: how and when to use the specific antidotes
Beverley J. Hunt, London, UK

11:45-12:00 Management of DOAC-associated bleeding: how and when to use prothrombin complex concentrates
David Faraoni, Toronto, ON, Canada

12:00-12:15 Discussion


Congressi Room No. 4

HOW TO IMPLEMENT PBM IN REAL LIFE
– WHAT CAN WE LEARN FROM THE MASTERS

WORKSHOP WITH ROUNTABLE DISCUSSIONS

Toby Richards, London, UK
Marco Pavesi, Milan, Italy


Roundtable participants

Elvira Bisbe, Barcelona, Spain
Jeffrey L. Carson, New Brunswick, NJ, USA
Jean-François Hardy, Montreal, QC, Canada
Sigismond Lasocki, Angers, France
Giancarlo Liumbruno, Rome, Italy
Jens Meier, Linz, Austria
Manuel Muñoz, Málaga, Spain
Marco Ranucci, Milan, Italy
Beatrice Rondinelli, Rome, Italy
Aryeh Shander, Englewood, NJ, USA
Cynthia So-Osman, Leiden, The Netherlands
Dafydd Thomas, Swansea, Wales, UK
Philippe Van der Linden, Brussels, Belgium
Luca Weltert, Rome, Italy
Kai Zacharowski, Frankfurt, Germany




12:15-13:30 Lunchtime industry-sponsored satellite symposia and workshops

13:30-14:00 Break


Thursday, April 20, 2017

AFTERNOON

Auditorium

MASSIVE BLEEDING AND COAGULOPATHY
– WHERE ARE WE AND WHERE SHOULD WE GO?

Jakob Stensballe, Copenhagen, Denmark
Vanessa Agostini, Cesena, Italy


14:00-14:15 Coagulopathy in bleeding patients – a 2017 overview
Jean-François Hardy, Montreal, QC, Canada

14:15-14:30 Coagulopathy of acute critical illness is in fact shock-induced endotheliopathy
Pär I. Johansson, Copenhagen, Denmark

14:30-14:45 Resuscitation of massive bleeding – state of art in 2017
John B. Holcomb, Houston, TX, USA

14:45-15:00 What trigger for RBC transfusion after control of massive bleeding?
Jeffrey L. Carson, New Brunswick, NJ, USA

15:00-15:30 Discussion


Verde Room

PATIENT BLOOD MANAGEMENT IN CRITICAL CARE
– WHAT’S NEW?

Dafydd Thomas, Swansea, Wales, UK
Massimo Girardis, Modena, Italy


14:00-14:15 PBM in the ICU
Jens Meier, Linz, Austria

14:15-14:30 Iron deficiency in the ICU – new evidence on clinical impact and diagnostic methods
Sigismond Lasocki, Angers, France

14:30-14:45 Intravenous iron in anaemic critically ill patients – the IRONMAN trial
Toby Richards, London, UK

14:45-15:00 Erythropoiesis-stimulating agents – any room for them?
Cynthia So-Osman, Leiden, The Netherlands

15:00-15:15 Alternatives to platelet transfusion – what can we offer?
Simon J. Stanworth, Oxford, UK

15:15-15:30 Discussion

15:30-16:00 Break


Auditorium

BREAKING NEWS

Jean-François Hardy, Montreal, QC, Canada
Antonio Corcione, Naples, Italy


 
16:00-16:15 Improved outcomes and reduced costs associated with a health-system–wide patient blood management programme
Axel Hofmann, Zurich, Switzerland

16:15-16:30 Effect of solvent/detergent-treated pooled plasma on endothelial integrity in patients undergoing emergency surgery for thoracic aortic dissections
Jakob Stensballe, Copenhagen, Denmark

16:30-16:45 Discussion

 

NATA FIREWORKS LECTURE
– THE VERY BEST OF ITALY

16:45-17:15 Understanding the mechanisms of the placebo effect
Fabrizio Benedetti, Turin, Italy

17:15-17:35 Panel discussion: How to manage the effect of placebo - for better or for worse - in future randomised controlled trials

Roundtable participants

Fabrizio Benedetti, Turin, Italy
Jeffrey L. Carson, New Brunswick, NJ, USA
David Faraoni, Toronto, ON, Canada
John B. Holcomb, Houston, TX, USA
Berverley J. Hunt, London, UK
Marco Ranucci, Milan, Italy
Simon J. Stanworth, Oxford, UK
Jakob Stensballe, Copenhagen, Denmark


17:45-18:00 NATA General Assembly



Friday, April 21, 2017

MORNING

Auditorium

TRANSFUSION IN PERSPECTIVE

Rainer Moog, Cottbus, Germany
Giovanni Inghilleri, Milan, Italy

 
9:00-9:15 Red blood cell storage duration and transfusion outcomes – what now?
Giancarlo Liumbruno, Rome, Italy

9:15-9:30 Red blood cell transfusion thresholds – 2016 AABB clinical practice guidelines
Jeffrey L. Carson, New Brunswick, NJ, USA

9:30-9:45 Red cell and platelet transfusion in haematological malignancies – where do we stand?
Simon J. Stanworth, Oxford, UK

9:45-10:00 Plasma products: freeze-dried, liquid or concentrates - what’s new?
Thomas Frietsch, Marburg, Germany

10:00-10:30 Discussion


Verde Room

FIBRINOGEN SUBSTITUTION
– WHAT DOES THE EVIDENCE SAY?

Beverley J. Hunt, London, UK
Evgeny Fominskiy, Milan, Italy

 
9:00-9:20 Fibrinogen in paediatric cardiac surgery: the FIB-CON trial – breaking RCT news
Kristina Siemens, London, UK

9:20-9:40 Fibrinogen in trauma haemorrhage – breaking RCT news
Jakob Stensballe, Copenhagen, Denmark

9:40-10:00 The status of fibrinogen in cardiothoracic surgery
Jens Meier, Linz, Austria

10:00-10:30 Discussion

10:30-11:00 Break


Auditorium

BEST POSTERS
– PRESENTATIONS AND AWARDS (PART 1)

Elvira Bisbe, Barcelona, Spain
Beatrice Rondinelli, Rome, Italy

 
11:00-11:07 Patient blood management in patients undergoing arthroplasty for fractured neck of femur – Results from a UK National Comparative Audit in 2015
Kate Pendry, Manchester, UK

11:07-11:14 Management of perioperative blood transfusion in surgical treatment of adolescent idiopathic scoliosis – One-centre experience in 210 cases
Jakob Stensballe, Copenhagen, Denmark

11:14-11:21 Vampirism in the intensive care unit: a routine practice?
Manuel Quintana Díaz, Madrid, Spain

11:21-11:28 Severity of preoperative anaemia is associated with increased mortality in children undergoing surgical procedures and not improved by preoperative red cell transfusions
Ruchika Goel, New York, NY, USA

11:28-11:35 Exploring the effects of iron deficiency anaemia and repletion with intravenous iron on exercise performance in c57 wild type mice
Anna Butcher, London, UK

11:35-11:42 The use of intravenous ferric carboxymaltose in the immediate postpartum period in a UK teaching hospital
Jayne Halcrow, Dundee, Scotland, UK

11:42-11:49 A randomised, patient-blind, placebo-controlled, Phase III clinical study of intravenous ferric carboxymaltose for acute isovolaemic anaemia following gastrectomy (FAIRY)
Young-Woo Kim, Goyang, Republic of Korea

11:49-11:56 Treatment cost effects of perioperative anaemia treatment with ferric carboxymaltose
Bernd Froessler, Adelaide, SA, Australia

11:56-12:15 Poster awards


Verde Room

BEST POSTERS
– PRESENTATIONS AND AWARDS (PART 2)

Jens Meier, Linz, Austria
Giovanni Albano, Bergamo, Italy

 
11:00-11:07 Prescription of red blood cell transfusions by implementation of a simple checklist for physicians
Robert Slappendel, Antwerp, Belgium

11:07-11:14 Red blood cell order alert override justifications
Melissa Cushing, New York, NY, USA

11:14-11:21 Efficacy of a “zero tolerance” policy on appropriateness of plasma transfusion
Ivo Beverina, Legnano, Italy

11:21-11:28 Maintenance of platelet function in stored irradiated and non-irradiated platelet concentrates with the platelet additive solution SSP+
Rainer Moog, Cottbus, Germany

11:28-11:35 Platelet transfusion sustains count but is associated with decreased function in severely injured trauma patients
Charles E. Wade, Houston, TX, USA

11:35-11:42 Comparison of two diagnostic scores of disseminated intravascular coagulation in pregnant women admitted to the ICU
Anne-Sophie Ducloy-Bouthors, Lille, France

11:42-11:49 Speed-up bleeding investigation for therapeutic optimisation (SUBITO): an interdisciplinary approach to intraoperative patient blood management
Till Hoffmann, Düsseldorf, Germany

11:49-11:56 Can thromboelastography really assess coagulation in anemic patients?
Andrei Braester, Ramat Gan, Israel

11:56-12:15 Poster awards



12:15-13:30 Lunchtime industry-sponsored satellite symposia and workshops

13:30-14:00 Break


Friday, April 21, 2017

AFTERNOON

Auditorium

WOMEN’S HEALTH – FOCUS ON BLEEDING, IRON DEFICIENCY AND MORTALITY

Manuel Muñoz, Málaga, Spain
Toby Richards, London, UK

 
14:00-14:20 The WOMAN trial – breaking news
Beverley J. Hunt, London, UK

14:20-14:40 Iron deficiency, anaemia and mortality – focus on low-income countries
Dora Pereira, Cambridge, UK

14:40-15:00 Iron deficiency, anaemia and mortality – focus on high-income countries
Susan Robinson, London, UK

15:00-15:30 Discussion


15:30 Concluding comments
Jean-François Hardy, Montreal, QC, Canada